Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFiske Regulatory News (FKE)

Share Price Information for Fiske (FKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.50
Bid: 70.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 15.00 (21.429%)
Open: 77.50
High: 77.50
Low: 77.50
Prev. Close: 77.50
FKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

20 Aug 2015 09:42

RNS Number : 5556W
Fiske PLC
20 August 2015
 



20 August 2015

 

Fiske Plc 

('Fiske' or 'the Company')

 

Final Results

 

Fiske is pleased to announce its final results for the twelve months ended 31 May 2015.

 

In accordance with rule 26 of the AIM Rules for Companies, this information is also available under the Investor Relations section of the Company's website, http://www.fiskeplc.com .

 

For further information please contact:

 

• Gerard Luchini, Fiske Plc - Company Secretary

(tel: 020 7448 4700)

 

• Salmaan Khawaja/Richard Tonthat/Harrison Clarke, Grant Thornton UK LLP (Nominated Adviser)

(tel: 020 7383 5100)

Chairman's Statement

 

 

The past year has proved to be disappointing in revenue terms and at the same time we have incurred material non-recurring expenditure. These costs include substantial investment in systems which will continue for another six months. As a result we have made a loss for the year of £645,000 and will not be paying a second interim dividend.

However we are confident that our decision to upgrade our systems will greatly enhance the service we provide to our clients which in turn will enable us to expand our business profitably.

Although currency movements have reduced the value of our holding in Euroclear, which is denominated in Euros, the company is trading very successfully. Its profit after tax for the six months to 30th June 2015 was up by 15% against the same period in the previous year. We remain confident that this will prove to be a good investment for Fiske.

Current trading is lacklustre however our balance sheet remains robust and we continue to keep a tight rein on our costs. We continue to view the future with confidence.

As I do each year I would like to invite our shareholders to attend our Annual General Meeting. We like the opportunity to meet you and for you to meet the management of the company in which you are invested. This year the AGM is on Thursday, 24th of September at Fiske's offices in Salisbury House at 12:30 pm. Please note that the Circus Place entrance to Salisbury House is closed and entry to the building can be gained from either London Wall or Finsbury Circus.

 

Clive Fiske Harrison

Chairman

20 August 2015

 

 

 

 

Directors' Report

 

The Directors present their report together with the audited financial statements for the year ended 31 May 2015.

Directors' interests - Shares

The Directors who served during the year and to the date of this report and their beneficial interests, including those of their spouses, at the end of the year in the shares of the Company were as follows:

 

 

Ordinary

25p shares

at 31 May 2015

Ordinary

25p shares

at 31 May 2014

A J Andrews (resigned 31 May 2015)

18,000

3,000

S J Cockburn (resigned 25 September 2014)

421,227

421,227

A R F Harrison

315,842

315,842

C F Harrison

2,334,828

2,334,828

J P Q Harrison†

2,140,802

2,140,802

F G Luchini

45,000

24,000

A D Meech

100,000

100,000

M H W Perrin

15,000

15,000

† Including 2,133,802 shares held by LongSand Limited, a company controlled by JPQ Harrison.

There have been no changes in the Directors' shareholdings since 31 May 2015.

Directors' interests - Share options

Details of Directors' options over ordinary shares are as follows:

Number of options

 

At start

of year

Granted

during

year

Exercised

during

year

Expired

during

year

 

At end

of year

 

Exercise

price

Market price

on date of

exercise

Date from which

exercisable

F G Luchini - Unapproved

75,000

-

-

-

75,000

28.75p

-

1 May 2005

The closing mid-market price of the Company's ordinary 25p shares at 31 May 2015 was 63.5p (2014: 57.5p).

Major shareholdings

Shareholders holding more than 3% of the shares of the Company at the date of this report were:

Ordinary shares

%

C F Harrison

2,334,828

27.60

J P Q Harrison

2,140,802

25.30

S J Cockburn

421,227

4.98

Craven Hill Limited

396,413

4.69

Mrs C M Short

386,029

4.56

A R F Harrison

315,842

3.73

B A F Harrison

280,000

3.31

Capital Structure

Details of the authorised and issued share capital, together with details of the movements in the Company's issued share capital during the year are shown in note 22.

The holders of Ordinary Shares are entitled to receive notice of and to attend and vote at any General Meeting of the Company. Every member present at such a meeting shall, upon a show of hands, have one vote. Upon a poll, holders of all shares shall have one vote for every share held. All ordinary shares are entitled to participate in any distributions of the Company's profits or assets.

There are no restrictions on the transfer of the Company's ordinary shares. Fiske plc's ordinary 25p shares are traded solely on the AIM market.

 

Dividends

A first interim dividend of 0.25p per share was paid on 20 March 2015 (2014: 0.35p) It is not intended to pay a second interim dividend (2014: 0.35p per share). Net assets of the Group at 31 May 2015 were £4,455,000.

Going Concern

After making due and careful enquiry, the Directors have formed a judgement at the time of approving the financial statements, that there is a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. For this reason the Directors continue to adopt the going concern basis in preparing the financial statements as set out in note 1 to the accounts.

Directors' indemnities

The Company has made qualifying third party indemnity provisions for the benefit of its Directors which were renewed during the year and remain in force at the date of this report.

Disclosure of information to auditor

Each of the persons who is a Director at the date of approval of this annual report confirms that:

(i) so far as the Director is aware, there is no relevant audit information of which the Company's auditor is unaware; and

(ii) the Director has taken all the steps that he/she ought to have taken as a Director to make himself/herself aware of any relevant audit information and to establish that the Company's auditor is aware of that information.

This confirmation is given and should be interpreted in accordance with the provisions of Section s418 of the Companies Act 2006.

Auditor

The Directors review the terms of reference for the auditor and obtain written confirmation that the firm has complied with its relevant ethical guidance on ensuring independence. Deloitte LLP provide audit services to the Company and Group as well as tax compliance and advisory services. The Board reviews the level of their fees to ensure they remain competitive and to ensure no conflicts of interest arise.

Deloitte LLP has expressed a willingness to continue in office as auditor and a resolution to reappoint them will be proposed at the forthcoming Annual General Meeting.

 

By Order of the Board

F G LuchiniSecretary

20 August 2015

 

 

Salisbury House

London Wall

London EC2M 5QS

 

 

 

 

 

 

 

Consolidated Statement of Total Comprehensive Income

For the year ended 31 May 2015

 

 

Notes

2015

2014

 

£'000

£'000

Continuing Operations

 

Fee and commission income

3

3,090

4,178

Fee and commission expenses

3

(558)

(1,139)

Net fee and commission income

 

2,532

3,039

Other income

3

67

132

Total Revenue

 

2,599

3,171

 

Profit on investments held for trading

 

-

3

Operating expenses

 

(3,328)

(3,061)

Operating (loss)/profit

6

(729)

113

 

Investment revenue

 

67

134

Finance income

7

20

22

Finance costs

8

(3)

(1)

(Loss)/Profit on ordinary activities before taxation

 

(645)

268

Taxation

9

133

(37)

(Loss)/Profit on ordinary activities after taxation

 

(512)

231

Other comprehensive (loss)/income

 

Items that may subsequently be reclassified to profit or loss

 

Movement in unrealised (depreciation) / appreciation of investments

 

(153)

69

Deferred tax on movement in unrealised appreciation of investments

 

34

(10)

Net other comprehensive (loss)/income

 

(119)

59

Total comprehensive (loss)/income attributable to equity shareholders

 

(631)

290

(Loss) / earnings per ordinary share

 

Basic

11

(6.1p)

2.7p

Diluted

11

(6.0p)

2.7p

 

 

All results are from continuing operations.

 

 

 

Consolidated Statement of Financial Position

31 May 2015

 

Notes

2015

2014

 

£'000

£'000

 

Non-current Assets

 

Goodwill

12

395

395

Other intangible assets

13

90

-

Property, plant and equipment

14

27

35

Available-for-sale investments

16

2,217

2,365

Total non-current assets

 

2,729

2,795

 

 

Current Assets

 

Trade and other receivables

17

4,460

5,810

Investments held for trading

18

13

124

Cash and cash equivalents

19

2,456

3,957

Total current assets

 

6,929

9,891

Current liabilities

 

Trade and other payables

20

5,032

7,211

Current tax liabilities

 

-

38

Total current liabilities

 

5,032

7,249

Net current assets

 

1,897

2,642

 

Non-current liabilities

 

Deferred tax liabilities

21

171

300

Total non-current liabilities

 

171

300

 

Net Assets

 

4,455

5,137

 

 

 

 

EQUITY

 

Share capital

22

2,115

2,115

Share premium

 

1,222

1,222

Revaluation reserve

 

1,142

1,261

Retained earnings

 

(24)

539

Shareholders' equity

 

4,455

5,137

 

These financial statements were approved by the Board of Directors and authorised for issue on 19 August 2015.

Signed on behalf of the Board of Directors

 

J P Q Harrison

Chief Executive Officer

 

 

Parent Company Statement of Financial Position

31 May 2015

 

Notes

2015

2014

 

£'000

£'000

 

Non-current Assets

 

Goodwill

12

230

230

Other intangible assets

13

90

-

Property, plant and equipment

14

27

35

Investments in subsidiary undertakings

15

165

165

Available-for-sale investments

16

2,217

2,365

Total non-current assets

 

2,729

2,795

 

 

Current Assets

 

Trade and other receivables

17

4,460

5,810

Investments held for trading

18

13

124

Cash and cash equivalents

19

2,456

3,957

Total current assets

 

6,929

9,891

Current liabilities

 

Trade and other payables

20

5,032

7,211

Current tax liabilities

 

-

38

Total current liabilities

 

5,032

7,249

Net current assets

 

1,897

2,642

 

Non-current liabilities

 

Deferred tax liabilities

21

171

300

Total non-current liabilities

 

171

300

 

Net Assets

 

4,455

5,137

 

 

 

 

EQUITY

 

Share capital

22

2,115

2,115

Share premium

 

1,222

1,222

Revaluation reserve

 

1,142

1,261

Retained earnings

 

(24)

539

Shareholders' equity

 

4,455

5,137

 

These financial statements were approved by the Board of Directors and authorised for issue on 19 August 2015.

Signed on behalf of the Board of Directors

 

J P Q Harrison

Chief Executive Officer

 

 

Group and Parent Company Statement of Changes in Equity

For the year ended 31 May 2015

 

Share

capital

Share premium

Revaluation reserve

Retained earnings

Total

£'000

£'000

£'000

£'000

£'000

Balance at 1 June 2013

2,115

1,222

1,202

359

4,898

Revaluation of available-for-sale investments

-

-

69

-

69

Deferred tax on revaluation of available-for-sale investments

-

-

(10)

-

(10)

Profit for the financial year

-

-

-

231

231

Dividends paid

-

-

-

(51)

(51)

Balance at 1 June 2014

2,115

1,222

1,261

539

5,137

Revaluation of available-for-sale investments

-

-

(153)

-

(153)

Deferred tax on revaluation of available-for-sale investments

-

-

34

-

34

(Loss) for the financial year

-

-

-

(512)

(512)

Dividends paid

-

-

-

(51)

(51)

Balance at 31 May 2015

2,115

1,222

1,142

(24)

4,455

 

 

Group and Parent Company Cash Flow Statement

For the year ended 31 May 2015

 

 

2015

2014

 

£'000

£'000

Operating (loss)/profit

(729)

113

Depreciation of property, plant and equipment

24

27

Decrease/(increase) in investments held for trading

111

(89)

Decrease in receivables

1,388

6,704

(Decrease) in payables

(2,179)

(5,560)

Cash (used in)/generated from operations

(1,385)

1,195

Tax paid

(38)

(50)

Net cash (used in)/generated from operating activities

 

(1,423)

1,145

 

 

Investing activities

 

Interest received

 

20

22

Investment income received

 

67

134

Interest paid

 

(3)

-

Purchases of available-for-sale investments

 

(5)

-

Purchases of property, plant and equipment

 

(16)

(24)

Purchases of other intangible assets

 

(90)

-

Net cash (used in)/generated from investing activities

 

(27)

132

 

 

Financing activities

 

Dividends paid

 

(51)

(51)

Net cash used in financing activities

 

(51)

(51)

 

 

Net (decrease)/increase in cash and cash equivalents

 

(1,501)

1,226

Cash and cash equivalents at beginning of year

 

3,957

2,731

Cash and cash equivalents at end of year

 

2,456

3,957

 

 

 

 

 

 

Notes to the Accounts

For the year ended 31 May 2015

1 Accounting policies

General information

Fiske plc is a limited company incorporated in the United Kingdom and registered in England and Wales, company number 02248663. The address of its registered office and principal place of business are disclosed in the Company Information page of the Financial Statements.

The principal activities of the Company are described in the Directors' Report.

 

At the date of authorisation of these financial statements, the following standards and interpretations, were in issue but not yet effective, and have not been early adopted by the Group:

Issued, but not yet EU adopted:

• IFRS 9, Financial instruments

• IFRS 14, Regulatory deferral accounts

• IFRS 15, Revenue from contracts with customers

• Amendment to IAS 19, Employee contributions

• Amendment to IFRS 11, Accounting for acquisitions of interests in joint operations

• Amendments to IAS 16 and IAS 38, Clarification of acceptable methods of depreciation and amortisation

• Amendments to IAS 16 and IAS 41, Bearer plants

• Amendment to IFRS 10, IFRS 12 and IAS 28, Investment entities, applying the consolidation exemption

• Amendments to IAS 1, Disclosure initiative

• Amendments to IAS 27, Equity method in separate financial statements

• Amendments to IFRS 10 and IAS 28, Sale of contribution of assets between an investor and its associate or joint venture

Issued and EU adopted:

• IFRIC 21, Levies

Whilst the Directors do not anticipate the adoption of these standards and interpretation in future reporting periods will have a material impact on the Group's financial statements, they have yet to complete their full assessment in relation to the impact of IFRS 15.

 

(a) Basis of preparation

These financial statements have been prepared in accordance with the requirements of IFRS implemented by the Group for the year ended 31 May 2015 as adopted by the European Union and International Financial Reporting Interpretations Committee and with the Companies Act 2006. The Group financial statements have been prepared under the historical cost convention, with the exception of financial instruments, which are stated in accordance with IAS 39 Financial Instruments: recognition and measurement. The principal accounting policies are set out below.

(b) Going concern basis

The Group's activities, together with the factors likely to affect its future development, performance and position are set out in the Strategic Report on pages 3 and 4. It also includes the Group's objectives, policies and processes for managing its business risk objectives, which includes its exposure to credit, market and operational risks. The Group continues to hold a substantial cash resource. After making enquiries, the Directors have formed a judgement, at the time of approving the financial statements, that there is a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. For this reason the Directors continue to adopt the going concern basis in preparing the financial statements.

(c) Basis of consolidation

The Group financial statements incorporate the financial statements of the Company and entities controlled by the Company (its subsidiaries) made up to 31 May each year. Control is achieved where the Company is exposed, or has rights, to variable returns from its involvement with an investee company and has the ability to affect those returns through its power over the other entity; power generally arises from holding a majority of voting rights.

(d) Revenue recognition

The Group follows the principles of IAS 18, 'Revenue Recognition', in determining appropriate revenue recognition policies. In principle, therefore, revenue is recognised to the extent that the economic benefits associated with the transaction will flow into the Group.

· Commission: Commission income and expenses are recognised on a trade date basis.

· Fees: Investment management, administration and corporate finance fees are recognised when earned with retainer fees being recognised over the length of time of the agreement.

· Dividend income: Dividend income is recognised when the right to receive payment is established.

(e) Segment reporting

IFRS 8 requires that an entity disclose financial and descriptive information about its reportable segments, which are operating segments or aggregations of operating segments. Operating segments are identified on the basis of internal reports that are regularly reviewed by the Chief Executive Officer to allocate resources and to assess performance. Using the Group's internal management reporting as a starting point the single reporting segment set out in note 3 has been identified.

(f) Business combinations

The acquisition of subsidiaries is accounted for using the purchase method. The cost of acquisition is measured as the aggregate of the fair values, at the date of exchange, of the assets given, liabilities incurred or assumed, and equity instruments issued by the Group in exchange for control of the acquiree, plus any costs directly attributable to the business combination. The acquiree's identifiable assets, liabilities and contingent liabilities that meet the conditions for recognition under IFRS 3 are recognised at their fair value at the acquisition date. As permitted by IFRS 1, the Group has chosen not to restate, under IFRS, business combinations that took place prior to 1 June 2006, the date of transition to IFRS.

(g) Goodwill

Goodwill arising on consolidation represents the excess of the cost of acquisition over the Group's interest in the fair value of the identifiable assets and liabilities of a subsidiary, associate or jointly controlled entity at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less any impairment. Goodwill which is recognised as an asset is reviewed for impairment at least annually. Any impairment is recognised immediately and is not subsequently reversed.

For the purpose of impairment testing, goodwill is allocated to each of the Group's cash-generating units expected to benefit from the synergies of the combination. Cash-generating units to which goodwill has been allocated are tested for impairment annually, or more frequently where there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying value of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro rata on the basis of the carrying value of each asset in the unit. An impairment loss recognised for goodwill is not reversed in a subsequent period.

On disposal of a subsidiary, associate or jointly controlled entity, the attributable amount of goodwill is included in the determination of the profit or loss on disposal. Goodwill arising on acquisitions before the date of transition to IFRSs has been retained at the previous UK GAAP amounts subject to being tested for impairment at that date.

(h) Property, plant and equipment

All property, plant and equipment are shown at cost less subsequent depreciation and impairment. Cost includes expenditure that is directly attributable to the acquisition of items. Depreciation is charged so as to write off the cost or valuation of assets over their useful economic lives, using the straight-line method, which is considered to be as follows:

Office refurbishment - 5 years

Office furniture and fittings - 4 years

Computer equipment - 3 years

The assets' residual values and useful lives are reviewed, and if appropriate asset values are written down to their estimated recoverable amounts, at each balance sheet date. Gains and losses on disposals are determined by comparing proceeds with the carrying amounts, and are included in the income statement.

 

 

 

 

(i) Impairment of intangible assets

The Group's policy is to amortise the intangible assets over the life of the contract.

At each balance sheet date, the Group reviews the carrying amounts of its intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where the asset does not generate cash flows that are independent from other assets, the Group estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value, using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised as an expense immediately.

(j) Available-for-sale investments

Available-for-sale investments are recognised and derecognised on a trade date where a purchase or sale of an investment is effected under a contract whose terms require delivery of the investment within the timeframe established by the market concerned, and are initially measured at cost.

At subsequent reporting dates, available-for-sale investments are measured at fair value. Gains or losses arising from changes in fair value are recognised directly in equity, until the security is disposed of or is determined to be impaired, at which time the cumulative gain or loss previously recognised in equity is included in the net profit or loss for the period. Impairment losses recognised in profit or loss are not subsequently reversed through profit or loss.

The fair values of available-for-sale investments quoted in active markets are determined by reference to the current quoted bid price. Where independent market prices are not available, fair values may be determined using valuation techniques with reference to observable market data.

(k) Trade and other receivables

Trade and other receivables are measured at initial recognition at fair value, and are subsequently measured at amortised cost using the effective interest rate method. Appropriate allowances for estimated irrecoverable amounts are recognised in profit or loss when there is objective evidence that the asset is impaired. The allowance recognised is measured as the difference between the asset's carrying amount and the present value of estimated future cash flows discounted at the effective interest rate computed at initial recognition.

(l) Investments held for trading

Investments held for trading, are measured at market value.

(m) Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and demand deposits, and other short-term highly liquid investments that are readily convertible to known amounts of cash and are subject to insignificant risk of changes in value. Such investments are those with original maturities of three months or less.

(n) Client money

The Company holds money on behalf of clients in accordance with the Client Money Rules of the Financial Conduct Authority. With the exception of money arising in the course of clients' transactions, as disclosed in note 19, such monies and the corresponding liability to clients are not shown on the face of the balance sheet. The amount so held on behalf of clients at the year-end is stated in note 25.

(o) Trade and other payables

Trade and other payables are measured at initial recognition at fair value, and are subsequently measured at amortised cost using the effective interest rate method. The Group accrues for all goods and services consumed but as yet unbilled at amounts representing management's best estimate of fair value.

(p) Equity instruments

Equity instruments issued by the Company are recorded at the proceeds received, net of direct issue costs.

(q) Dividends

Equity dividends are recognised when paid.

 

 

(r) Share-based payments

Where share options are awarded to employees, the fair value of the options at the date of grant is charged to the income statement over the vesting period. Non-market vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each balance sheet date so that, ultimately, the cumulative amount recognised over the vesting period is based on the number of options that eventually vest. Market vesting conditions are factored into the fair value of the options granted. As long as all other vesting conditions are satisfied, a charge is made irrespective of whether the market vesting conditions are satisfied. The cumulative expense is not adjusted for failure to achieve a market vesting condition.

When the terms and conditions of options are modified before they vest, the increase in the fair value of the options, measured immediately before and after the modification, is also charged to the income statement over the remaining vesting period. Where equity instruments are granted to persons other than employees, the income statement is charged with the fair value of the goods and services received. There has been no material share options charge to the income statement to date and therefore no disclosure appears in these financial statements.

(s) Taxation

The tax expense represents the sum of the tax currently payable and the deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The Group's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.

Deferred tax is the tax expected to be payable or recoverable on differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit, and is accounted for using the balance sheet liability method. Deferred tax liabilities are generally recognised for all taxable temporary differences and deferred tax assets are recognised to the extent that it is probable that taxable profits will be available against which deductible temporary differences can be utilised. Such assets and liabilities are not recognised if the temporary difference arises from the initial recognition of goodwill or from the initial recognition (other than in a business combination) of other assets and liabilities in a transaction that affects neither the taxable profit nor the accounting profit.

Deferred tax liabilities are recognised for taxable temporary differences arising on investments in subsidiaries and associates, except where the Group is able to control the reversal of the temporary difference and it is probable that the temporary difference will not reverse in the foreseeable future.

The carrying amount of deferred tax assets is reviewed at each balance sheet date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity.

Deferred tax assets and liabilities are offset where there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Group intends to settle its current tax assets and liabilities on a net basis.

(t) Foreign currencies

The individual financial statements of each Group company are presented in the currency of the primary economic environment in which it operates (its functional currency). For the purpose of the Group Financial Statements, the results and financial position of each Group company are expressed in pounds sterling, which is the functional currency of the Company, and the presentation currency for the Group Financial Statements.

In preparing the financial statements of the individual companies, transactions in currencies other than the entity's functional currency (foreign currencies) are recorded at the rates of exchange prevailing on the dates of the transactions. At each balance sheet date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the balance sheet date. Non-monetary items carried at fair value that are denominated in foreign currencies are translated at the rates prevailing at the date when the fair value was determined. Non-monetary items that are measured in terms of historical costs in a foreign currency are not retranslated.

Exchange differences arising on the settlement of monetary items, and on the retranslation of monetary items, are included in profit or loss for the period. Exchange differences arising on the retranslation of non-monetary items carried at fair value are included in profit or loss for the period except for differences arising on the retranslation

of non-monetary items in respect of which gains and losses are recognised directly in equity. For such non-monetary items, any exchange component of that gain or loss is also recognised directly in equity.

(u) Leases

Rentals payable under operating leases are charged to income on a straight-line basis over the term of the relevant lease. Benefits received and receivable as an incentive to enter into an operating lease are also spread on a straight-line basis over the lease term.

2 Critical accounting judgements and key uncertainties of estimation uncertainty

In the application of the Group's accounting policies, which are described in note 1, the Directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period.

Allowance for bad debts

The Group makes provision for the element of client receivables where and to the extent it believes will not be recovered from clients. This is based on past experience and detailed analysis of the outstanding position particularly with regard to the value of customers' portfolios relative to the amounts owed.

Fair value of investments

The Group currently holds an investment in Euroclear Plc, which is held as an available-for-sale financial asset and measured at fair value at the balance sheet date. The Euroclear Plc shares do not trade in an active market, and therefore fair value is calculated with reference to the most recently published Euroclear Plc financial statements and share buyback information, using a Directors' valuation.

Impairment

The assets on the balance sheet are reviewed for any indications of impairment. This is done with reference to the recoverability and market value of the assets concerned but may involve an element of judgement or estimation in determining whether there are any indications of impairment and if so, the extent of any impairment loss.

 

 

3 Total revenue and segmental analysis

IFRS 8 requires operating segments to be identified on the basis of internal reports about components of the Group that are regularly reviewed by the Chief Executive to allocate resources to the segments and to assess their performance. Pursuant to this, the Group continues to identify a single reportable segment, being UK-based financial intermediation. Within this single reportable segment, total revenue comprises:

2015

2014

£'000

£'000

Commission receivable

2,391

3,579

Investment management fees

699

599

3,090

4,178

Commission payable to associates

(555)

(1,134)

Commission payable to third parties

(3)

(5)

(558)

(1,139)

2,532

3,039

Other income

67

132

2,599

3,171

Substantially all revenue in the current and prior year is generated in the UK and derives solely from the provision of financial intermediation.

4 Staff remuneration and costs

Remuneration policies are recommended to the Board by the Remuneration Committee. The Committee consists of C F Harrison (Chairman), A R F Harrison and M H W Perrin.

Remuneration for executives comprises basic salary, a performance-related bonus, and other benefits in kind, and may include share options. This remuneration takes into account:

· market rates;

· the need to attract, retain and motivate high calibre individuals with a competitive remuneration package;

· comparability across different functions within the firm;

· loyalty and effort; and

· effectiveness.

The FCA's Remuneration Code applies to certain of the firm's staff. As set out in note 5 below Alan Meech receives a commission element generated by him and this is usually less than 33% of the total remuneration earned by him though it is not capped as such. All other Code Staff have salaries that are in the main fixed and any performance-related pay reflects a share of a bonus pool available to all employees. This bonus pool reflects the profitability of the firm in that year and is allotted according to merit.

The average number of employees, including Directors, employed by the Company within each category of persons, and their aggregate remuneration was:

2015

2015

2014

2014

No.

£'000

No.

£'000

Dealing and sales

11

627

9

537

Settlement

7

274

7

311

Administration

7

500

7

350

25

1,401

23

1,198

Employees', including Directors', costs comprise:

2015

2014

£'000

£'000

Wages, salaries and other staff costs

1,453

1,252

Bonus

1

25

Social security costs

155

153

1,609

1,430

 

5 Directors' remuneration

(a) Directors' emoluments comprise:

2015

2014

£'000

£'000

Emoluments

736

574

Highest paid Director's remuneration:

Emoluments

247

137

Information regarding Directors' share options is shown under Directors' Interests in the Directors' Report.

The emoluments of the Directors for the current and previous year are as follows:

 

 

Gross

salary

 

Termination

 

Fees

 

Commission

 

Benefits

 

Total

31 May 2015

£'000

 

£'000

£'000

£'000

£'000

A J Andrews

96

150

-

-

-

246

C F Harrison

119

-

-

-

6

125

J P Q Harrison

112

-

-

-

3

115

F G Luchini

77

-

-

-

36

113

A D Meech

61

-

-

19

16

96

M H W Perrin

-

-

24

-

-

24

A R F Harrison

-

-

17

-

-

17

 

465

150

41

19

61

736

 

 

 

Gross

salary

 

Termination

 

Fees

 

Commission

 

Benefits

 

Total

31 May 2014

£'000

 

£'000

£'000

£'000

£'000

A J Andrews

93

-

-

-

1

94

C F Harrison

126

-

-

-

11

137

J P Q Harrison

103

-

-

-

2

105

F G Luchini

107

-

-

-

4

111

A D Meech

74

-

-

20

4

98

S J Cockburn

-

-

10

-

-

10

M H W Perrin

-

-

17

-

-

17

A R F Harrison

-

-

2

-

-

2

 

503

-

29

20

22

574

6 Operating (loss)/profit

2015

2014

£'000

£'000

The operating (loss)/profit is arrived at after charging:

Auditor's remuneration:

Fees payable to the Company's auditor

- for the audit of the Company's annual accounts

 

 

57

 

 

57

Non-audit fees:

- Other services pursuant to legislation: Interim review

 

6

 

6

- Audit of client money and custody assets

8

8

- Tax services

7

13

Net foreign exchange losses

1

1

Depreciation of property, plant and equipment

24

26

Operating lease rentals - Land and buildings

180

178

- Other

5

5

The loss for the financial year dealt with in the financial statements of the parent Company was £607,000 (2014: profit of £231,000) before dividend.

As permitted by Section 408 of the Companies Act 2006, no separate income statement is presented in respect of the parent Company.

7 Finance income

2015

2014

£'000

£'000

Interest receivable:

Banks

20

22

20

22

 

8 Finance costs

2015

2014

£'000

£'000

Interest payable:

Bank loans, overdrafts and other interest payable

3

1

 

9 Tax

Analysis of tax (credit)/charge on ordinary activities:

2015

2014

£'000

£'000

Current tax

Current year

(38)

38

Prior year adjustment

-

(2)

(38)

36

Deferred tax

Current year

(95)

1

Prior year adjustment

-

-

Total tax (credit)/charge (to Statement of Comprehensive Income)

(133)

37

Factors affecting the tax charge for the year

The standard rate of tax for the year, based on the United Kingdom standard rate of corporation tax, is 20% (2014: 22.67%).

The (credit)/charge for the year can be reconciled to the profit per the Statement of Comprehensive Income as follows:

2015

2014

£'000

£'000

(Loss)/profit before tax

(645)

268

Charge on profit on ordinary activities at standard rate

(129)

61

Effect of:

Expenses not deductible in determining taxable profit

11

11

Non-taxable income

(11)

(27)

Small company relief

(4)

(6)

Adjustment to tax charge in respect of prior years

-

(2)

(133)

37

 

 

 

 

 

10 Dividends paid

2015

2014

£'000

£'000

Second interim dividend of 0.35p (October 2013: 0.25p) paid in respect of prior year

30

21

First interim dividend of 0.25p (March 2014: 0.35p)

21

30

51

51

 

The Employee Share Option Scheme, which is controlled by Fiske plc held shares to the benefit of employees, waived the entitlement to any dividend on its holding of 9,490 ordinary shares of 25p each (2014: 9,490 ordinary shares of 25p each).

11 Earnings per share

Basic earnings per share has been calculated by dividing the profit on ordinary activities after taxation by the weighted average number of shares in issue during the year. Diluted earnings per share is basic earnings per share adjusted for the effect of conversion into fully paid shares of the weighted average number of share options during the year.

 

31 May 2015

 

Basic

Diluted

Basic

£'000

£'000

Loss on ordinary activities after taxation

(512)

(512)

Adjustment to reflect impact of dilutive share options

-

-

Earnings

(512)

(512)

Number of shares (000's)

8,451

8,489

Loss per share (pence)

(6.1)

(6.0)

 

 

31 May 2014

 

Basic

Diluted

Basic

£'000

£'000

Profit on ordinary activities after taxation

231

231

Adjustment to reflect impact of dilutive share options

-

-

Earnings

231

231

Number of shares (000's)

8,451

8,489

Earnings per share (pence)

2.7

2.7

 

31 May 2015

31 May 2014

Number of shares (000's):

Weighted average number of shares

8,451

8,451

Dilutive effect of share option scheme

38

38

8,489

8,489

 

 

12 Goodwill

Positive goodwill arising out of Fund management acquisitions

 

Group

Company

 

£'000

£'000

Cost

At 1 June 2013

1,311

1,146

Additions

-

-

At 1 June 2014

1,311

1,146

Additions

-

-

At 31 May 2015

1,311

1,146

Accumulated impairment losses

At 1 June 2013

916

916

Impairment losses for the year

-

-

At 1 June 2014

916

916

Impairment losses for the year

-

-

At 31 May 2015

916

916

Carrying amount

At 31 May 2015

395

230

At 1 June 2014

395

230

At 1 June 2013

395

230

Goodwill reflects cost, less any impairment provisions deemed appropriate. Further detail is set out in note 1 to the accounts. Goodwill is allocated to a cash generating unit, which is the Company itself and the recoverable amount of the cash generating unit is determined by calculating the fair value, on the basis of 2.5% of assets under management, less costs to sell.

13 Other intangible assets

 

 

 

Systems

licence

 

Total

Group and Company

 

 

£'000

£'000

Cost

At 1 June 2013

282

282

At 1 June 2014

282

282

Additions

90

90

At 31 May 2015

372

372

Accumulated amortisation

At 1 June 2013

282

282

Charge for the year

-

-

At 1 June 2014

282

282

Charge for the year

-

-

At 31 May 2015

282

282

Net book value

At 31 May 2015

90

90

At 31 May 2014

-

-

At 31 May 2013

-

-

 

 

 

 

14 Property, plant and equipment

 

Office furniture and equipment

 

Computer equipment

 

Office refurbishment

 

 

Total

Group and Company

£'000

£'000

£'000

£'000

Cost

At 1 June 2013

129

122

175

426

Additions

5

19

-

24

Disposals

-

-

-

-

At 1 June 2014

134

141

175

450

Additions

-

16

-

16

Disposals

-

-

-

-

At 31 May 2015

134

157

175

466

Accumulated depreciation

At 1 June 2013

99

114

175

388

Charge for the year

15

12

-

27

Disposals

-

-

-

-

At 1 June 2014

114

126

175

415

Charge for the year

10

14

-

24

Disposals

-

-

-

-

At 31 May 2015

124

140

175

439

Net book value

At 31 May 2015

 

10

 

17

 

-

 

27

At 31 May 2014

20

15

-

35

At 31 May 2013

30

8

-

38

15 Investment in subsidiary undertakings

2015

2014

Company

£'000

£'000

Cost at 1 June 2014 and 31 May 2015

165

165

The following are the subsidiaries of the Company at 31 May 2015 and at the date of these financial statements.

Incorporated in the UK:

 

Class of shares

Proportion of

Nominal value and voting rights held by parent company

Nature of business

VOR Financial Strategy

Ordinary

100%

Investment

Ionian Group Limited

Ordinary

100%

Investment

Fiske Nominees Limited

Ordinary

100%

Nominee

 

 

16 Available-for-sale investments

2015

2014

Group and Company

£'000

£'000

At 1 June 2014:

Valuation

2,365

2,296

Unrealised appreciation

(1,561)

(1,492)

Cost

804

804

Additions

5

-

Cost of disposals

-

-

At 31 May 2015:

Cost

809

804

Unrealised appreciation

1,408

1,561

Valuation

2,217

2,365

being:

Listed

164

158

Unlisted

2,053

2,207

Available-for-sale investments carried at fair value

2,217

2,365

The investments included above are represented by holdings of equity securities. These shares are not held for trading and are accordingly classified as available-for-sale.

17 Trade and other receivables

2015

2014

Group and Company

£'000

£'000

Counterparty debtors

2,846

4,378

Trade receivables

1,182

1,034

4,028

5,412

Corporation tax recoverable

38

-

Other debtors

20

12

Prepayments and accrued income

374

386

4,460

5,810

Trade receivables

Included in the Group's trade receivables balance are debtors with a carrying amount of £877,000 (2014: £14,000) which are past due at the reporting date for which the Group has not provided as there has not been a significant change in credit quality and the amounts were still considered recoverable, and were subsequently recovered.

Ageing of past due but not impaired trade receivables:

2015

2014

£'000

£'000

0 - 15 days

836

13

16 - 30 days

41

-

31 - 60 days

-

1

877

14

 

 

Counterparty receivables

Included in the Group's counterparty receivables are debtors with a carrying amount of £21,000 (2014: £10,000) which are past due at the reporting date for which the Group has not provided as there has not been a significant change in credit quality and the amounts were still considered recoverable, and were subsequently recovered.

Ageing of past due but not impaired counterparty receivables:

2015

2014

£'000

£'000

0 - 30 days

3

7

31 - 60 days

18

3

21

10

18 Investments held for trading

2015

2014

Group and Company

£'000

£'000

Listed

13

124

The investments included above are represented by holdings of listed equity securities.

19 Cash and cash equivalents

Cash and cash equivalents includes £493,000 (2014: £1,405,000) received in the course of settlement of client trades. This amount is held by the Company in trust on behalf of clients but may be utilised to complete settlement of outstanding trades.

20 Trade and other payables

 

2015

2014

 

Group

Group

£'000

£'000

Counterparty creditors

1,811

5,172

Trade payables

2,625

1,543

4,436

6,715

Sundry creditors and accruals

596

496

5,032

7,211

21 Deferred taxation

 

 

Capital allowances

Available-

for-sale investments

 

Tax

Losses

 

Deferred tax liability

Group and Company

£'000

£'000

£'000

£'000

At 1 June 2014

-

300

-

300

Credit for the year

(1)

-

(94)

(95)

Credit in respect of prior year

-

-

-

-

Charge to Statement of Comprehensive Income

- in respect of current year

-

-

-

-

- in respect of change in corporation tax rate

-

(34)

-

(34)

At 31 May 2015

(1)

266

(94)

171

Deferred tax assets and liabilities are recognised at a rate which is substantively enacted at the balance sheet date. The rate to be taken in this case is 20%, being the anticipated rate of taxation applicable to the Company in the future.

 

22 Called up share capital

 

2015

2014

No. of shares

£'000

No. of shares

£'000

Authorised:

Ordinary shares of 25p

12,000,000

3,000

12,000,000

3,000

Allotted and fully paid:

Ordinary shares of 25p

8,460,205

2,115

8,460,205

2,115

Included within the allotted and fully paid share capital were 9,490 ordinary shares of 25p each (2014: 9,490 ordinary shares of 25p each) held for the benefit of employees.

At 31 May 2015 there were 75,000 outstanding options to subscribe for ordinary shares.

23 Contingent liabilities

In the ordinary course of business, the Company has given letters of indemnity in respect of lost certified stock transfers and share certificates. While the contingent liability arising thereon is not quantifiable, it is not believed that any material liability will arise under these indemnities.

24 Financial commitments

Operating leases

At 31 May 2015 the Group had outstanding commitments for future minimum lease payments under non-cancellable operating leases which fall due as follows:

 

2015

2014

 

Land and buildings

Other

Land and buildings

Other

£'000

£'000

£'000

£'000

In the next year

103

5

177

5

In the second to fifth years inclusive

-

2

103

7

Total commitment

103

7

280

12

In June 2010, the Company entered into a new lease over its premises at London Wall for a period of 10 years, with a five year break clause.

25 Clients' money

At 31 May 2015 amounts held by the Company on behalf of clients in accordance with the Client Money Rules of the Financial Conduct Authority amounted to £40,335,000 (2014: £38,254,000). The Company has no beneficial interest in these amounts and accordingly they are not included in the balance sheet.

26 Financial instruments

Capital risk management

The Group manages its capital to ensure that it will be able to continue as a going concern while maximising the return to stakeholders. The Group's capital structure consists of equity attributable to equity holders of the parent company, comprising issued capital, reserves and retained earnings. The Group has no debt.

Externally imposed capital requirement

The Group is subject to the minimum capital requirements required by the Financial Conduct Authority (FCA), and has complied with those requirements throughout both financial periods. Capital adequacy and capital resources are monitored by the Group on the basis of the Capital Requirements Directive. The Group has a strong balance sheet, and has maintained regulatory capital at a level in excess of its regulatory requirement. The Group's capital requirement is under continuous review as part of the Internal Capital Adequacy Assessment Process.

Significant accounting policies

Details of the significant accounting policies and methods adopted, including the criteria for recognition, the basis for measurement and the basis on which income and expenses are recognised, in respect of each class of financial asset, financial liability and equity instrument, are disclosed in the accounting policies in note 1.

Categories of financial instruments

2015

2014

Group and Company

£'000

£'000

Available-for-sale investments

2,217

2,365

Loans and receivables - Trade and other receivables

4,460

5,810

Loans and receivables - Cash and cash equivalents

2,456

3,957

Investments held at fair value through profit and loss

13

124

Financial liabilities at amortised cost - Trade and other payables

5,032

7,211

The carrying value of each class of financial asset denoted above approximates to its fair value.

Fair value measurements recognised in the statement of financial position

The following table provides an analysis of financial instruments that are measured subsequent to initial recognition at fair value, grouped into Levels 1 to 3 based on the degree to which the fair value is observable:

· Level 1 fair value measurements are those derived from quoted prices (unadjusted) in active markets for identical assets or liabilities;

· Level 2 fair value measurements are those derived from inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and

· Level 3 fair value measurements are those derived from valuation techniques that include inputs for the asset or liability that are not based on observable market data (unobservable inputs).

 

2015

 

Level 1

Level 2

Level 3

Total

£'000

£'000

£'000

£'000

Financial assets at FVTPL

Derivative financial assets for trading

-

-

-

-

Non-derivative financial assets for trading

13

-

-

13

Available-for-sale financial assets

Quoted equities

164

-

-

164

Unquoted equities

-

-

2,053

2,053

Total

177

-

2,053

2,230

There were no transfers between levels during the year.

Reconciliation of Level 3 fair value measurements of financial assets

Available-for-sale financial assets

 

 

Unquoted equities

Total

 

 

£'000

£'000

Balance at 1 June 2014

2,207

2,207

Purchases

-

-

Total gains or losses:

(154)

(154)

Balance at 31 May 2015

2,053

2,053

There were no reclassifications during the year. There were no financial liabilities subsequently measured at fair value.

The Group's finance function monitors and manages the financial risks relating to the operations of the Group. The Group is exposed to market and other price risk, credit risk and to a very limited amount interest rate risk and liquidity risk.

The Board of Directors monitors risks and implements policies to mitigate risk exposures.

Credit risk

Credit risk refers to the risk that a third party will default on its contractual obligations resulting in financial loss to the Group. Third party receivables consist of customers' balances, spread across institutional and private clients. Ongoing credit evaluation is performed on the financial condition of accounts receivable and stock is held until settlement is effected.

The Group does not have any significant credit risk exposure to any group of third parties having similar characteristics. The credit risk on liquid funds is limited because the third parties are one of the UK big four clearing banks.

Market risk

The Group is mainly exposed to market risk in respect of its trading as agent in equities and debt instruments with the volume of trading and thus transaction revenue retreating in market downturns, and to variations in asset values and thus management fees. There has been no material change to the Group's exposure to market risks or the manner in which it manages and measures the risks.

Market risk also gives rise to variations in the value of investments held by Fiske, acting as principal. These are designated as available-for-sale and are mostly held for strategic rather than trading purposes and not actively traded.

Interest rate risk management

The Group has no borrowings and is therefore not exposed to interest rate risk in that respect. The Group's exposure to interest rates on financial assets is detailed in the liquidity risk management section of this note.

Liquidity risk management

The Group manages liquidity risk by maintaining adequate reserves and by continuously monitoring forecast and actual cash flows and matching the maturity profiles of financial assets and liabilities. In respect of counterparty creditors and trade payables the amounts due are all payable between nil and 15 days.

Sensitivity analysis

Equity

The fair values of all available-for-sale investments and their exposure to equity price risks at the reporting date are based on the accounting policy in note 1(j). If equity prices had been 5% higher/lower the revaluation reserve would increase/decrease by £111,000 (2014: increase/decrease by £118,000).

In respect of investments held for trading purposes and their exposure to equity price risks at the reporting date, if equity prices had been 5% higher, net profit for the year ended 31 May 2015 would have been £1,000 higher (2014: £6,000 higher) and vice versa if prices were lower.

Cash

The Group's financial cash asset of £2,456,000 (2014: £3,957,000) is held at a fixed interest rate and is available on demand. If prevailing interest rates during the year (approximately 0.5%) had been comparable with those prevailing in the prior year (approximately 0.5%), bank interest receivable of £20,000 (2014: £22,000) would have been substantially unchanged. A further reduction in rates in the period would have had no material impact.

27 Related party transactions

Transactions between the Company and its subsidiaries which are related parties have been eliminated on consolidation and are not disclosed in this note as they are not material.

Directors' transactions

The Group and Company received, by way of a service fee, £nil (2014: £81,632) from The Investment Company Plc, a company of which M.H.W Perrin is a Director and holds an interest, in respect of administrative, accounting and clerical support and the supply of facilities on an arm's length basis.

Directors transact share-dealing business with the Company under normal staff business terms and in accordance with applicable laws and regulations. In the year to 31 May 2015, commission earned from this by the Company amounted to £1,207 (2014: £2,404).

During the year, the Directors each received dividends attributable to their respective shareholdings, as disclosed in the Directors' Report, amounting to 0.6p (2014: 0.6p) per ordinary share.

Details of Directors' interests in ordinary shares and in share options are as disclosed in the Directors' Report, together with details of other significant holdings in the equity of the Company. The Company has no ultimate controlling party.

Directors' balances

The Directors' trading balances have been included within trade receivables and payables and Directors' current account balances are included in other payables.

 

Company Information

 

DIRECTORS

Clive Fiske Harrison

Chairman

James Philip Quibell Harrison

Chief Executive Officer

Francis Gerard Luchini

Compliance Director and Company Secretary

Alan Dennis Meech

Director

Martin Henry Withers Perrin*

Alexander Rupert Fiske Harrison *

*Non-Executive

REGISTERED OFFICE

3rd Floor, Salisbury House

London Wall

London EC2M 5QS

 

NOMINATED ADVISER

Grant Thornton UK LLP

30 Finsbury Square

London EC2P 2YU

 

REGISTERED NUMBER

02248663

 

AUDITOR

Deloitte LLP

London

 

AIM Listing

Lon:FKE

ISIN: GB0003353157

Sedol: 0335315

REGISTRARS

Capita Asset Services Limited

The Registry

34 Beckenham Road

Beckenham, Kent BR3 4TU

 

Details of the Directors and their backgrounds are as follows:

Clive Fiske Harrison Chairman

Clive Harrison started his career with Panmure Gordon in 1961 and moved to Hodgson & Baker (subsequently renamed Sandleson & Co) in 1965. He founded Fiske & Co in 1973 and has been senior partner and latterly Chief Executive officer since that time. He retired from the role of Chief Executive following the AGM on 25 September 2014.

James Philip Quibell Harrison Chief Executive Officer

James Harrison joined Fiske in 1996 in the private client investment department and now manages a substantial client portfolio. He was Company Secretary from 2001 to 2005 and he was appointed to the Board as an Executive Director in May 2007. On 25 September 2014, following the AGM he was appointed as the Chief Executive Officer. He is responsible for the day to day running of the Company.

Francis Gerard Luchini Compliance Director

Gerard Luchini joined Fiske as Compliance Officer in July 1997 and became a Director in January 1998. He was formerly a Compliance Officer with the Royal Bank of Canada. He has responsibility for all compliance and regulatory matters at the firm. He was appointed Company Secretary in 2005.

Alan Dennis Meech Director

Alan Meech joined Fiske as a dealer in 1985 and became a Director in May 1989. He was previously with J M Finn. His role at Fiske, principally on the dealing desk, also includes responsibility for some areas of credit control.

Martin Henry Withers Perrin Non-Executive

Martin Perrin joined the Board as a non-executive Director in November 2003. He is a chartered accountant with wide experience of operations and finance in industry. He is Chairman of the Audit Committee and the Risk Management Committee and is a member of the Remuneration and Nomination Committee. He is a Director of The Investment Company Plc and Vipera plc.

Alexander Rupert Fiske Harrison Non-Executive

Alexander Fiske Harrison joined the Board as a non-executive Director in April 2015. He has previously worked for the Financial Times Group where he was involved in setting up the FT Magazine in 2003 and has also worked as a trainee stockbroker at Fiske plc. Alexander is currently a director of St. Botolph's Securities Limited and Mersea Island Securities Limited, both of which are investment companies. Alexander also sits on the Board of Mephisto Productions Limited, a company involved the production of film and theatre.

Notice of Annual General Meeting

 

Notice is hereby given that the Annual General Meeting of Fiske plc will be held at Salisbury House, London Wall, London EC2M 5QS on 24 September 2015 at 12.30 pm for the following purposes:

Ordinary Business:

1. To receive the Report of the Directors and Auditor and the Accounts for the year ended 31 May 2015.

2. To re-elect Martin Henry Withers Perrin as a director of the Company.

3. To re-elect Clive Fiske Harrison as a director of the Company.

4. To re-elect Francis Gerard Luchini as a director of the Company.

5. To reappoint Deloitte LLP as auditor and to authorise the Board to fix their remuneration.

Special Business

To consider and, if thought fit, to pass the following Resolutions which will be proposed as to Resolution 6 as an ordinary Resolution and as to Resolutions 7 and 8 as special Resolutions:

6. THAT for the purposes of section 551 Companies Act 2006 ("2006 Act") (and so that expressions used in this resolution shall bear the same meanings as in the said section 551):

(a) the Directors be generally and unconditionally authorised to exercise all powers of the Company to allot shares and to grant such subscription and conversion rights as are contemplated by sections 551(1)(a) and (b) of the 2006 Act respectively up to a maximum nominal amount of £634,515 to such persons and at such times and on such terms as they think proper during the period expiring at the conclusion of the next Annual General Meeting of the Company (unless previously varied, revoked or renewed by the Company in general meeting); and

(b) the Company shall be entitled to make, prior to the expiry of such authority, any offer or agreement which would or might require relevant securities to be allotted after the expiry of such authority and the Directors may allot any relevant securities pursuant to such offer or agreement as if such authority had not expired; and

(c) all prior authorities to allot securities be revoked but without prejudice to the allotment of any securities already made or to be made pursuant to such authorities.

7. THAT:

(a) the Company be and is hereby generally and unconditionally authorised for the purpose of section 701 of the Companies Act 2006 (the "2006 Act") to make market purchases (within the meaning of section 693 of the 2006 Act) of ordinary shares of 25p each in the capital of the Company ("ordinary shares") on such terms and in such manner as the Directors may from time to time determine provided that:

(b) the maximum number of ordinary shares hereby authorised to be acquired is 846,020;

(c) the minimum price which may be paid for an ordinary share is 25p;

(d) the maximum price which may be paid for an ordinary share is an amount equal to 105% of the average of the middle market quotations for an ordinary share as derived from The London Stock Exchange Daily Official List for the five business days immediately preceding the day on which an ordinary share is contracted to be purchased;

(e) unless previously revoked or varied, the authority hereby conferred shall expire at the close of the next Annual General Meeting of the Company or 18 months from the date on which this resolution is passed, whichever shall be the earlier; and

(f) the Company may make a contract to purchase ordinary shares under the authority hereby conferred prior to the expiry of such authority, which contract will or may be executed wholly or partly after the expiry of such authority, and may purchase ordinary shares in pursuance of any such contract.

8. THAT the Directors be granted power pursuant to Section 570 of the Companies Act 2006 to allot equity securities (within the meaning of section 560 of the 2006 Act) for cash, pursuant to the authority conferred on them to allot such shares or grant such rights by Resolution 5 contained in the Notice of the Annual General Meeting of the Company of which this Resolution forms part as if section 561(1) and sub sections (1)-(6) of section 562 of the 2006 Act did not apply to any such allotment, provided that the power conferred by this Resolution shall be limited to:

(a) the allotment of equity securities in connection with an issue or offering in favour of holders of equity securities and any other persons entitled to participate in such issue or offering where the equity securities respectively attributable to the interests of such holders and persons are proportionate (as nearly as maybe) to the respective number of equity securities held or deemed to be held by them on the record date of such allotment, subject only to such exclusions or other arrangements as the Directors may consider necessary or expedient to deal with fractional entitlements or legal or practical problems under the laws or requirements of any recognised regulatory body or stock exchange in any territory; and

(b) the allotment of equity securities up to an aggregate nominal value of £211,500; and

(c) shall expire at the conclusion of the next Annual General Meeting of the Company or, if earlier, the date 15 months from the date of passing of this Resolution unless previously varied, revoked or renewed by the Company in general meeting provided that the Company may, before such expiry, make any offer or agreement which would or might require equity securities to be allotted after such expiry and the Directors may allot equity securities pursuant to any such offer or agreement as if the power hereby conferred had not expired; and

(d) all prior powers granted under section 571 of the Companies Act 2006 be revoked provided that such revocation shall not have retrospective effect.

 

By Order of the Board

F G Luchini

Secretary

20 August 2015

Registered office:

Salisbury House

London Wall

London EC2M 5QS

 

Notes to Notice of Annual General Meeting

1. A member entitled to attend and vote at the Meeting convened by the above notice may appoint a proxy to exercise all or any of his rights to attend, speak and vote at a meeting of the Company. A proxy need not be a member of the Company. A member may appoint more than one proxy in relation to the Meeting, provided that each proxy is appointed to exercise the rights attached to a different share or shares held by that member. A form of proxy is enclosed. To be valid the enclosed form of proxy together with the power of attorney or other authority, if any, under which it is signed or a notarially certified or office copy thereof, must be delivered in accordance with instructions on it so as to be received by the Company's registrars, Capita Asset Services, Proxies, The Registry, 34 Beckenham Road, Beckenham BR3 4TU, not less than two working days before the time appointed for holding the Meeting or any adjournment thereof. Lodgement of a form of proxy will not prevent a member from attending and voting in person if so desired.

2. Copies of contracts of service between the directors and the Company will be available at the registered office of the Company on any weekday prior to the meeting (weekends and public holidays excepted) during normal business hours. Copies of the above-mentioned documents will also be available on the date of the Annual General Meeting at the place of the meeting for 15 minutes prior to the meeting until its conclusion.

3. Pursuant to section 360B of the 2006 Act and regulation 41 of the Uncertificated Securities Regulations 2001, only shareholders registered in the register of members of the Company as at two working days before the time appointed for holding the Meeting shall be entitled to attend and vote at the Meeting in respect of the number of shares registered in their name at such time. If the Meeting is adjourned, the time by which a person must be entered on the register of members of the Company in order to have the right to attend and vote at the adjourned meeting is at 12.30 pm on the day preceding the date fixed for the adjourned meeting. Changes to the register of members after the relevant times shall be disregarded in determining the rights of any person to attend or vote at the Meeting.

4. In the case of joint holders, the vote of the senior who tenders a vote whether in person or by proxy will be accepted to the exclusion of the votes of the other joint holders and for this purpose seniority will be determined by the order in which names stand in the register of members of the Company in respect of the relevant joint holding.

5. By attending the Meeting members agree to receive any communications made at the meeting.

6. In order to facilitate voting by corporate representatives at the Meeting, arrangements will be put in place at the Meeting so that (i) if a corporate shareholder has appointed the Chairman of the Meeting as its corporate representative to vote on a poll in accordance with the directions of all of the other corporate representatives for that shareholder at the Meeting, then on a poll those corporate representatives will give voting directions to the Chairman and the Chairman will vote (or withhold a vote) as corporate representative in accordance with those directions; and (ii) if more than one corporate representative for the same corporate shareholder attends the Meeting but the corporate shareholder has not appointed the Chairman of the Meeting as its corporate representative, a designated corporate representative will be nominated, from those corporate representatives who attend, who will vote on a poll and the other corporate representatives will give voting directions to that designated corporate representative. Corporate shareholders are referred to the guidance issued by the Institute of Chartered Secretaries and Administrators on proxies and corporate representatives (www.icsa.org.uk) for further details of the procedure. The guidance includes a sample form of appointment letter if the Chairman is being appointed as described in (i) above.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR PKCDDOBKDCFD
Date   Source Headline
15th Apr 20244:27 pmRNSDirector Dealing
6th Mar 202411:51 amRNSDirector Dealing
22nd Feb 20241:21 pmRNSDirector Dealing
19th Feb 20244:38 pmRNSDirector Dealing
16th Feb 20242:47 pmRNSDirector Dealing
16th Feb 20247:00 amRNSInterim results
8th Dec 20234:56 pmRNSDirector Dealing
28th Nov 20233:38 pmRNSDirector Dealing
23rd Nov 202312:52 pmRNSResult of AGM and Confirmation of Board Changes
30th Oct 20233:42 pmRNSDirector Dealing
24th Oct 20237:00 amRNSFinal Results, Annual Report and Notice of AGM
22nd Aug 20231:19 pmRNSDirector dealing
6th Jul 20237:00 amRNSDirector Dealing
31st May 20233:27 pmRNSDirector Dealing
4th Apr 202312:38 pmRNSDirector Dealing
3rd Apr 202310:55 amRNSDirector Dealing
3rd Apr 20237:00 amRNSAcquisition of Client Book
2nd Mar 20237:00 amRNSInterim results
29th Nov 20221:58 pmRNSDirector Dealings
24th Nov 20225:31 pmRNSResult of AGM
20th Oct 20227:00 amRNSFinal Results, Annual Report and Notice of AGM
18th Aug 20229:30 amRNSHolding(s) in Company
17th Jun 20224:13 pmRNSDirector Dealing
1st Mar 20227:00 amRNSHalf-year Report
17th Dec 20214:47 pmRNSDirector Dealing
10th Dec 20217:00 amRNSChange to Accounting Year End
30th Nov 20217:00 amRNSChange of Registered Office
25th Oct 202110:56 amRNSResult of AGM
30th Sep 202111:23 amRNSTotal Voting Rights
29th Sep 20215:29 pmRNSDirector Dealing
17th Sep 20211:08 pmRNSDirector Shareholding & Director Dealing
17th Sep 20219:58 amRNSExercise of Share Options and Issue of Equity
14th Sep 20219:44 amRNSFinal Results, Annual Report and Notice of AGM
5th Jul 202112:56 pmRNSHolding(s) in Company
28th May 20214:21 pmRNSDirector Dealings and Director Shareholding Update
20th Apr 20217:00 amRNSDirector Shareholding Disclosure
19th Feb 20217:00 amRNSInterim Results
8th Feb 20215:28 pmRNSForm 8.3 - Marston's PLC
23rd Dec 20202:46 pmRNSResult of AGM
3rd Dec 202010:01 amRNSDirector Dealing
30th Nov 202012:20 pmRNSIssue of Equity
30th Nov 20207:00 amRNSFinal Results, Posting of Report and Notice of AGM
16th Nov 20207:30 amRNSSale of Euroclear shares
12th Nov 202011:31 amRNSSale of Euroclear shares
22nd Sep 20202:41 pmRNSForm 8.3 - Deltic Energy Plc
27th Jul 20203:54 pmRNSForm 8.3 - Deltic Energy Plc
16th Jul 20207:00 amRNSDirector Retirement
8th Apr 20207:00 amRNSCovid-19 and Trading Update
10th Mar 20209:57 amRNSDirector Dealing
26th Feb 20207:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.